manufacturers of glp 1 drugs GLP-1 Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care List of GLP-1 Receptor Agonists
Description
459,460 The anti-inflammatory effects of GLP-1RAs contribute to the attenuation of atherosclerotic plaque lesion development through various mechanisms
Furthermore, PKA activation is known to inhibit AMPK in GIP receptor and GLP- 1 receptor signaling, which results in the transfer of TORC2 into the nucleus [66]
[Article] [PubMed] [PMC]19
No head-to-head trials comparing agents in these two classes are currently available to guide decision-making
